Next stop in the treatment of refractory systemic lupus erythematosus: B-cell targeted combined therapy.
Conclusion: Further randomized clinical trials are needed to examine this drug sequencing protocol in SLE patients.
PMID: 33081591 [PubMed - as supplied by publisher]
Source: Lupus - Category: Rheumatology Authors: Bela MM, Espinosa G, Cervera R Tags: Lupus Source Type: research